First Patient Expected to be Dosed Next Week with Intranasal Foralumab PET Scan Shows Presence of Untreated Neuroinflammation ...
MedPage Today on MSN
Alzheimer's Benefits May Continue After Donanemab Treatment Ends, Data Suggest
Early Alzheimer's patients who completed their course of donanemab therapy by 12 months had cognitive and functional benefits lasting for 2 additional years, reported Jennifer Zimmer, MD, of Eli Lilly ...
Microglial activity appears to determine when amyloid becomes biologically significant, reshaping how clinicians interpret ...
Obesity accelerates the rise of Alzheimer’s-related blood biomarkers far more rapidly than previously recognized. Long-term imaging and plasma data show that obese individuals experience much faster ...
HealthDay on MSN
RSNA: Faster Rate of Amyloid Accumulation Seen With Obesity
Increases in levels of blood biomarkers of Alzheimer disease seen over time for all participants, with faster rates of increase for individuals with obesity.
Clogged brain drainage spaces visible on MRI scans may serve as early predictors of Alzheimer’s before major brain damage occurs. Researchers from, Singapore (NTU Singapore) have found that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results